Gunhild Mari Mælandsmo

Title: Gunhild Mari Mælandsmo: Innovator in Photochemical Internalization

Introduction

Gunhild Mari Mælandsmo is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of molecular delivery systems, particularly in the context of cancer treatment and gene therapy. Her innovative approach has the potential to revolutionize how therapeutic molecules are introduced into cells.

Latest Patents

Mælandsmo holds a patent for a method titled "Photochemical internalization for virus-mediated molecule delivery into the cytosol." This patent describes a technique for introducing a molecule into the cytosol of a cell. The process involves contacting the cell with a photosensitizing agent, irradiating the cell with light to activate the agent, and subsequently introducing the desired molecule. This method is particularly relevant for applications in cancer treatment, gene therapy, and vaccination. She has 1 patent to her name.

Career Highlights

Gunhild Mari Mælandsmo is associated with PCI Biotech AS, where she continues to advance her research and development efforts. Her work focuses on enhancing the efficacy of therapeutic interventions through innovative delivery methods. Mælandsmo's contributions have been recognized within the scientific community, and she is regarded as a leading figure in her field.

Collaborations

Mælandsmo collaborates with notable colleagues, including Anders Høgset and Kristian Berg. Their combined expertise fosters a dynamic research environment that drives innovation in molecular delivery systems.

Conclusion

Gunhild Mari Mælandsmo is a trailblazer in the field of photochemical internalization, with a focus on improving therapeutic delivery methods. Her work holds promise for advancing cancer treatment and gene therapy, making her a significant contributor to modern medical science.